Invest1 distinct publisher3 min readPublished
The British Business Bank's £46m works out at £575,000 of public money for each of Zinc's 80 planned companies. That sum pays for a formation step, not a science company. The gap between the two is the bet.
The Investor · Invest desk

Compiled by The InvestorSomething wrong?How this is made
Divide the target size by the target count and each company gets £875,000 before a single fee is charged [2], of which £575,000 is public [3], and that figure explains what the British Business Bank has bought rather better than the language from Zinc co-founder Ella Goldner about discoveries that never become companies [15]. £875,000 incorporates a business, licenses the university IP, pays two or three salaries and buys perhaps eighteen months of runway - enough to get a company started, but not enough to run a clinical trial or build a pilot plant. If Zinc holds back half the fund for follow-on cheques, which is what a careful early manager does, the first cheque drops to about £437,500 and 80 becomes a number contingent on how many of the first tranche earn a second [8].
The public share is the more interesting term. £46m of £70m is 65.7% [1], where the same programme took 50% of Longwall Venture Partners' £100m fund, a gap of 15.7 points [4], so the Bank is cornerstoning rather than co-investing, and the £70m target is itself 2.5 times the £28m Zinc closed with the programme's help in 2022 [5]. Assume, purely to see the shape of the thing, that Zinc holds a tenth of its winners through to exit: returning 3x on £70m means £210m of proceeds, which at that ownership implies roughly £2.1bn of aggregate exit value across the portfolio [7]. Eighty companies is a way of buying more tickets to exactly one of those.
The multiple is probably the wrong yardstick. The more useful test has nothing to do with it, because the Enterprise Capital Funds programme exists to get new UK managers to a close in the first place [3], and if the £46m is buying market structure then the number to follow is how many of Zinc's companies raise priced rounds led by investors with no public money behind them. Against the $11.3bn that went into UK deep tech in the first eight months of 2026, most of it to AI infrastructure and defence [12], £70m is about six-tenths of one percent even at a notional one-for-one on the currency [6], which puts this fund upstream of that capital rather than bidding against it, manufacturing deals for other people to price.
The hands-on promise that the Bank's senior investment manager Misodzi Mukungurutse names as Zinc's differentiator [16] also gets divided by eighty, and the failure mode is observable on a date. If, three years out, most of the eighty have not raised from capital with no public money in it, then £46m financed eighty incorporations and a venture-building services business with a fund wrapped around it.
Ranked by verification strength, evidence, and original report placement.
The British Business Bank is going to invest as much as £46 million in Zinc's new Science-for-Impact Fund.
The £70 million Science-for-Impact Fund is intended to support 80 deep tech startups emerging from UK research in health and climate.
The commitment sits within the Bank's Enterprise Capital Funds programme, a scheme designed to assist new UK venture managers.
The Science-for-Impact Fund is the 55th fund within the ECF programme that the Bank has supported since it started, as part of a regular pattern of two to three commitments each year.
The Bank supported Zinc's earlier fund through the Enterprise Capital Funds programme when that £28 million round completed in 2022.
The Bank used the same ECF approach to secure Longwall Venture Partners' £100 million deeptech fund by investing £50 million.
Distinct publishers with included, body-backed reporting in this cluster.
1 article · September 2, 2026
Follow any of these and your For You feed starts watching them — no settings page required.
invest
A $3M bet that construction margin is decided before the concrete arrives1 distinct publisher
invest
European defence money went late-stage: $4.7B of a record $8.7B in 20251 distinct publisher
invest
A £10M battery round priced off a curtailment bill nobody has agreed the size of1 distinct publisher
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
One outlet, one announcement
The £46m, the £70m target, the 80 companies, the 55-fund programme count and even Longwall's 19.2x all reach us through a single Tech Funding News write-up of a British Business Bank announcement. No fund documents, no named private limited partners, no first-close confirmation. The $11.3bn UK deep tech figure arrives with no data provider attached, and our per-company arithmetic inherits whatever error sits in the £70m it divides.
Committed at the top, moving at the bottom
Zinc 'intends' to reach £70m, so today there is a public commitment and a pipeline rather than a fund. The motion is all at company level: SignaCor out of the March cardiovascular cohort, Speek working with NHS trusts across 600-plus families, Epiome and CellMine early. Nothing has yet been invested from this vehicle, and the manager's own comparator — an OrganOx-scale exit — belongs to Longwall.
The headline is 80 companies; the cheque is a formation grant
Most of the stretch comes from the framing rather than the reporting. Tech Funding News is honest enough to state that Zinc has no exit like Longwall's — but it sets the 19.2x beside Zinc's ambition, where a proof point borrowed from another firm reads like evidence for this one. Meanwhile 'turning lab science into startups' at £575,000 of public money each buys a company's first year, not a science company, and the language of fixing a leak in the system sits over a vehicle worth about 0.62% of annual UK deep tech flow.
Funder and fundraiser, same paragraph
Three voices appear: the Bank's managing director, the Bank's senior investment manager, and Zinc's managing partner — the institution deploying public money and the manager still raising against it, at a moment when roughly £24m of the target is outstanding. The Bank's own reassurance is baked in too: the '55th fund, two to three a year' line defends a programme's cadence as much as it dates a deal. No limited partner, competing manager or ECF sceptic is heard from.
Solid on the number, thin on the outcome
That a state bank said £46m is close to a matter of record, and the arithmetic that follows from £46m, £70m and 80 companies is simply arithmetic. Everything past that — whether 80 companies get built, whether pre-incorporation venture building holds ownership through later rounds, whether public capital here is crowding private money in or standing in for it — rests on one trade-press retelling of the two interested parties' account.